A recent network meta-analysis compared use of various AHM classes to each other and demonstrated that use of CCBs and ARBs was associated with a 12–17% reduced dementia risk compared with ACE inhibitors and beta blockers, but less so versus diuretics (7–11%). The gene discussed is ACE; the disease is dementia.